Page 2 - Laurus Bio News Today

Mumbai (Maharashtra) [India], January 22 (ANI/Hunk Golden and Media): CIIE.CO, in partnership with GFI India, has just released a first-of-its-kind landscape study of the cultivated meat ecosystem in India

CIIE.CO, in partnership with GFI India, has just released a first-of-its-kind landscape study of the cultivated meat ecosystem in India. Cultivated meat, produc

CIIE.CO, in partnership with GFI India, has just released a first-of-its-kind landscape study of the cultivated meat ecosystem in India. Cultivated meat, produc

Artificial Intelligence (AI) is now the most talked-about and talked-about issue in the world. BENGALURU TECH SUMMIT 2021

Scientists are trying to create meat in the lab that tastes, feels and smells like the real thing but does not hurt the pocket. The question is, will it sell?

Read more about Laurus Labs rallies 5% on credit rating upgrade; stock hits record high on Business Standard. The company is looking to build new capacities/facilities that would propel its growth in the coming years

Shares of Laurus Labs moved higher by 5 per cent to Rs 474.95 on the BSE in intra-day trade on Monday, erasing a 4.5 per cent fall witnessed in the past two trading days, on a strong growth outlook. The stock of the pharmaceutical company hit a record high of Rs 482.65 on April 29, the day on which the company announced its January-March quarter (Q4FY21) earnings. The company’s Q4 revenues grew 68.3 per cent year-on-year (YoY) to Rs 1,412 crore with strong growth across segments. Earnings b...

Laurus Labs net surges on higher sales Updated: Updated: Share Article AAA Drugmaker Laurus Labs has reported a consolidated net profit of ₹297 crore for the quarter ended March on the back of good show in key business segments. The drugmaker had posted a net profit of ₹110.15 crore in the same period last fiscal. Revenue from operations increased to ₹1,412 crore (₹839.14 crore). For the full fiscal, net profit stood at ₹984 crore (₹255.27 crore), while revenue from operations was ...

The drug makers consolidated net profit soared 170% to Rs 297 crore on 68% surge in net sales to Rs 1,412 crore in Q4 FY21 over Q4 FY20. On a consolidated basis, EBITDA grew 147% to Rs 477 crore in Q4 FY21 over Q4 FY20 while EBITDA margins stood at 34%. The board approved an interim dividend amounting to Re 0.80 per share. The net profit soared 286% to Rs 984 crore on 70% surge in net sales to Rs 4,814 crore in the year ended March 2021 (FY21) over the year ended March 2020 (FY20). EBITDA grew...

Laurus Labs’ Q4 net at ₹297 crore April 29, 2021 Its total revenue increased 68% at ₹1,412 crore Laurus Labs Ltd’s consolidated net profit more than doubled at ₹297 crore in the fourth quarter ended March 31, 2021 compared to ₹110 crore in the corresponding quarter of the previous fiscal. The total revenue increased 68 per cent at ₹1,412 crore. For the full year, the net profit increased 286 per cent to ₹984 crore on a revenue of ₹4,814 crore which registered 68 per cent inc...